L M G van de Watering
Overview
Explore the profile of L M G van de Watering including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
91
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hogervorst E, Rosseel P, van de Watering L, Brand A, Bentala M, van der Meer B, et al.
Neth Heart J
. 2018 Sep;
26(11):540-551.
PMID: 30232783
Objective: The EuroSCORE I was one of the most frequently used pre-operative risk models in cardiac surgery. In 2011 it was replaced by its successor the EuroSCORE II. This study...
2.
Dijkstra-Tiekstra M, van de Watering L, Rondeel J, Slomp J, de Wildt-Eggen J
Transfus Med
. 2014 Feb;
24(2):99-104.
PMID: 24506143
Objectives: To study the effect of extended storage of platelet concentrates (PCs) and the implementation of a new platelet pooling system for PCs on corrected count increment (CCI) after transfusion....
3.
Wiersum-Osselton J, van Tilborgh-de Jong A, Zijlker-Jansen P, van de Watering L, Brand A, van der Bom J, et al.
Vox Sang
. 2012 Aug;
104(2):127-34.
PMID: 22892067
Background And Objectives: It has been suggested that the rate of reported transfusion reactions is positively correlated with safety of the transfusion chain in a hospital. We evaluated this assumption...
4.
Bilgin Y, van de Watering L, Brand A
Neth J Med
. 2011 Nov;
69(10):441-50.
PMID: 22058263
For many years filtration for removal of leucocytes from red blood cell (RBC) and platelet transfusions was applied for selected patients to prevent cytomegalovirus (CMV) (re)activation, HLA immunisation and recurrent...
5.
Sitniakowsky L, Later A, van de Watering L, Bogaerts M, Brand A, Klautz R, et al.
Transfus Med
. 2011 Apr;
21(4):236-46.
PMID: 21518046
Aim: To determine the effect of red blood cell (RBC) transfusions during cardiac surgery on cytokine gene expression (GE) in relation to multiple organ failure (MOF) development after systemic inflammatory...
6.
Lange M, van Hilten J, van de Watering L, Bijnen B, Roumen R, Putter H, et al.
Br J Surg
. 2009 Jun;
96(7):734-40.
PMID: 19526613
Background: Perioperative red blood cell (RBC) transfusion may be associated with a poor prognosis in cancer surgery. Allogeneic leucocytes are assumed to play a causal role. This study evaluated the...
7.
Bilgin Y, van de Watering L, Eijsman L, Versteegh M, van Oers M, Brand A
Transfus Med
. 2007 Aug;
17(4):304-11.
PMID: 17680957
In two randomized trials in cardiac surgery we observed that leukoreduced allogeneic red blood cell (RBC) transfusions (LR) compared with standard buffy-coat-depleted RBC transfusions (BCD) resulted in lower rates of...
8.
Schonewille H, van de Watering L
Transfusion
. 2007 Feb;
47(2):357-8.
PMID: 17302788
No abstract available.
9.
Van Hulst M, Bilgin Y, van de Watering L, de Vries R, van Oers M, Brand A, et al.
Transfus Med
. 2005 Jun;
15(3):209-17.
PMID: 15943705
Cost-effectiveness of leucodepleted erythrocytes (LD) over buffy-coat-depleted packed cells (PC) is estimated from the primary dataset of a recently reported randomized clinical trial involving valve surgery (+/-CABG) patients. Data on...
10.
Bilgin Y, van de Watering L, Eijsman L, Versteegh M, Brand R, van Oers M, et al.
Circulation
. 2004 May;
109(22):2755-60.
PMID: 15148271
Background: Leukocytes in allogeneic blood transfusions are believed to be the cause of immunomodulatory events. A few trials on leukocyte removal from transfusions in cardiac surgery have been conducted, and...